glp 1 approved for pediatrics SCALE KIDS Trial: Evaluating Liraglutide's Role in Pediatric Obesity Management Pediatric obesity drug use increased

Glucagon-like peptide 1 receptor agonists (GLP1-RA) are indicated for the treatment of type 2 diabetes and more recently for weight loss

For one, it may support weight management by regulating appetite, so people can manage their calorie intake more effectively

Learn 10 proven treatment steps, a 3-stage diet plan, & when to see a specialist for lasting relief.

Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease and significantly increases cardiovascular risk and mortality

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Manage Weight